Bio Marin Pharmaceutical Inc. Appoints Greg Friberg, M.D. As Evp, Chief Research & Development Officer and James Sabry, M.D., Ph.D. As Evp, Chief Business Officer
Aug 21, 2024•over 1 year ago
Position
Vice President
Company
BioMarin Pharmaceutical
Description
BioMarin Pharmaceutical Inc. has announced the appointments of Greg Friberg, M.D. as Executive Vice President, Chief Research & Development Officer, succeeding Hank Fuchs, M.D., and James Sabry, M.D., Ph.D
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months